Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TNON files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Delisting (new) — Company received formal Nasdaq notice of non-compliance with listing requirements, which could lead to delisting if not remedied.
Tenon Medical receives Nasdaq delisting notice for failing $2.5M equity requirement
Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read
Key Changes
-
high
Nasdaq notified Tenon Medical on May 21, 2026 of non-compliance with minimum $2.5M stockholders' equity requirement; company reported only $1.9M equity as of March 31, 2026, a $605K shortfall.
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule verify on EDGAR → -
high
Company has until July 6, 2026 to submit compliance plan; if accepted, Nasdaq may grant up to 180 additional days (through mid-November 2026) to regain compliance.
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule verify on EDGAR → -
high
Failure to submit acceptable plan or regain compliance within extension period will trigger delisting proceedings, though company would retain appeal rights to Nasdaq Hearings Panel.
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule verify on EDGAR → -
medium
Company is evaluating options to regain compliance but provides no assurance plan will be accepted or compliance achieved; notice does not immediately affect trading.
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule verify on EDGAR →
Summary
Tenon Medical disclosed it received a deficiency notice from Nasdaq for failing to maintain the minimum $2.5 million stockholders' equity required for continued listing on the Capital Market. As of March 31, 2026, the company reported only $1.9 million in equity—a $605,000 shortfall—and does not meet alternative compliance standards.
This is a serious liquidity concern that puts the company's exchange listing at risk. The company has until July 6, 2026 to submit a compliance plan. If Nasdaq accepts the plan, it may grant up to 180 additional days to restore compliance. However, Tenon provided no specifics on how it intends to raise the required capital and offered no assurance its plan will succeed.
Failure to regain compliance would trigger delisting proceedings, though the company would retain appeal rights. For retail holders, the key risk is potential forced migration to over-the-counter markets, which typically means reduced liquidity, wider bid-ask spreads, and diminished institutional interest. The company's ability to raise capital or execute a reverse split in coming months will determine whether it retains its Nasdaq listing.
Section-by-Section Diff
Event · Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule
Tenon Medical received Nasdaq delisting notice for failing to maintain minimum $2.5M stockholders' equity; has 45 days to submit compliance plan.
Added in current filing · verify on EDGAR →
If the Company fails to submit a plan to regain compliance with the minimum stockholders’ equity standard, or the Company’s plan is not accepted, or if Nasdaq grants an extension but the Company does not regain compliance within the extension period, Nasdaq will provide notice that the Company’s securities will become subject to delisting.
If Tenon Medical fails to submit an acceptable compliance plan or cannot regain compliance within the extension period, its stock will be subject to delisting from Nasdaq. The company would have appeal rights to a Nasdaq Hearings Panel, which would stay any delisting action during the appeal process.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 30, 2026 · How we verify